IMMX
Price
$3.43
Change
-$0.02 (-0.58%)
Updated
Sep 22, 6:59 PM EST
67 days until earnings call
UBX
Price
$2.47
Change
-$0.12 (-4.63%)
Updated
Sep 22, 6:59 PM EST

Analysis and predictions IMMX vs UBX

Header iconIMMX vs UBX Comparison
Open Charts IMMX vs UBXBanner chart's image
Immix Biopharma
Price$3.43
Change-$0.02 (-0.58%)
Volume$161.76K
CapitalizationN/A
Unity Biotechnology
Price$2.47
Change-$0.12 (-4.63%)
Volume$9.07K
CapitalizationN/A
View a ticker or compare two or three
IMMX vs UBX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
IMMX vs. UBX commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a StrongBuy and UBX is a Hold.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (IMMX: $3.43 vs. UBX: $2.47)
Brand notoriety: IMMX and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 167% vs. UBX: 32%
Market capitalization -- IMMX: $55.86M vs. UBX: $36.07M
IMMX [@Biotechnology] is valued at $55.86M. UBX’s [@Biotechnology] market capitalization is $36.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMMX is a better buy in the long-term than UBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 6 TA indicator(s) are bullish while UBX’s TA Score has 3 bullish TA indicator(s).

  • IMMX’s TA Score: 6 bullish, 4 bearish.
  • UBX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, IMMX is a better buy in the short-term than UBX.

Price Growth

IMMX (@Biotechnology) experienced а +28.46% price change this week, while UBX (@Biotechnology) price change was -3.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

IMMX is expected to report earnings on Nov 29, 2023.

UBX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IMMX with price predictions.
OPEN
A.I.dvisor published
a Summary for UBX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IMMX($48.7M) has a higher market cap than UBX($36.1M). IMMX YTD gains are higher at: 49.782 vs. UBX (-9.854). IMMX has higher annual earnings (EBITDA): -11.41M vs. UBX (-45.52M). UBX has more cash in the bank: 69.1M vs. IMMX (12.7M). IMMX has less debt than UBX: IMMX (50K) vs UBX (43.1M). IMMX (0) and UBX (0) have equivalent revenues.
IMMXUBXIMMX / UBX
Capitalization48.7M36.1M135%
EBITDA-11.41M-45.52M25%
Gain YTD49.782-9.854-505%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.7M69.1M18%
Total Debt50K43.1M0%
TECHNICAL ANALYSIS
Technical Analysis
IMMXUBX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME17.180.16
+0.94%
GameStop Corp
CLAR7.420.03
+0.41%
Clarus Corp
GENI5.350.01
+0.19%
Genius Sports Limited
TTE65.610.09
+0.14%
TotalEnergies SE
RPID1.14N/A
N/A
Rapid Micro Biosystems

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and AVRO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and AVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-0.58%
AVRO - IMMX
30%
Poorly correlated
-0.65%
ORMP - IMMX
27%
Poorly correlated
-1.14%
PDSB - IMMX
25%
Poorly correlated
-1.70%
VSTM - IMMX
24%
Poorly correlated
+2.11%
UBX - IMMX
23%
Poorly correlated
-4.63%
More

UBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with GMDA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then GMDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
-4.63%
GMDA - UBX
54%
Loosely correlated
-6.20%
NCNA - UBX
43%
Loosely correlated
N/A
NTLA - UBX
36%
Loosely correlated
-3.40%
DAWN - UBX
34%
Loosely correlated
+3.00%
CRSP - UBX
33%
Poorly correlated
-1.24%
More